Irving Investors — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Brian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)
BoardAndrew Farquharson(Director)inJak Knowles(Director)
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more
Snyk is a developer-focused security platform that identifies and fixes vulnerabilities in code, dependencies, containers, and cloud infrastructure using AI-powered analysis.
AI & Machine LearningCybersecurityDeveloper ToolsBoston, US
Guy Podjarny(Founder)inPeter McKay(Executive Officer, Director)inStephanie Dominy(Executive Officer)inAssaf Hefetz(Founder)Danny Grander(Founder)Peter McKay (CEO)(Founder)
Co-investors2050 CapitalAccelAlkeon InnovationAmity VenturesAmplify PartnersAtlassian Ventures+45 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













